Oleg I. Pisarenko
3rd Cherepkovskaya Str, 15A
Moscow, MOW 121552, Russian Federation
Moscow, MOW 121552, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
The preconditioning effect of a structural analogue of apelin-12 in a rat model of acute myocardial infarction.
Journal: Biomeditsinskaia khimiia
Published: November 10, 2025
The study of biodegradation of galanin and its N-terminal fragments in a model system in vitro.
Journal: Biomeditsinskaia khimiia
Published: March 06, 2025
Galanin Reduces Myocardial Ischemia/Reperfusion Injury in Rats with Streptozotocin Diabetes.
Journal: Acta naturae
Published: September 16, 2024
Apelin C-Terminal Fragments: Biological Properties and Therapeutic Potential.
Journal: Biochemistry. Biokhimiia
Published: December 17, 2023
Exogenous GalR2-specific peptide agonist as a tool for treating myocardial ischemia/reperfusion injury.
Journal: Fundamental & clinical pharmacology
Published: March 11, 2023
The anti-ischemic and antioxidant activity of the pharmacological agonist of galanin receptor GalR2 and carnosine in in vitro and in vivo model systems
Journal: Biomeditsinskaia khimiia
Published: June 19, 2022
Chimeric Agonist of Galanin Receptor GALR2 Reduces Heart Damage in Rats with Streptozotocin-Induced Diabetes.
Journal: Biochemistry. Biokhimiia
Published: May 09, 2022
Modified N-Terminal Fragments of Galanin: Cardioprotective Properties and Mechanisms of Action.
Journal: Biochemistry. Biokhimiia
Published: December 14, 2021
The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin.
Journal: Acta naturae
Published: June 02, 2020
Last Updated: 09/26/2026